YoungGPSt JohnDJBWinawerSJChoice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies. A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy] report. Am J Gastroenterol2002;97:2499–507.
11.
AdamsECLaymanKM.Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci1974;4:343–9.
12.
BarrowsGHBurtonRMJarrettDDImmunochemical detection of human blood in feces. Am J Clin Path1978;69:342–6.
13.
SaitoHTsuchidaSFukushiMAn immunological occult blood test for mass screening of colorectal cancer by reverse passive hemagglutination (RPHA). Jap J Gastroenterol1984;81:2831–3.
YoungGPSt JohnDJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res1991;18:135–56.
16.
RockeyDCAuslanderAGreenbergPD.Detection of upper gastrointestinal blood with fecal occult blood tests. Am J Gasroenterol1999;94:344–50.
17.
AllisonJETekawaISRansomUA comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med1996:334:154–9.
18.
AdlercreutzHPartanenPVirkolaPFive guaiac-based tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest1984;44:519–28.
19.
St JohnDJBYoungGPAlexeyeffMAEvaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology1993;104:1661–8.
20.
LevinBHessKJohnsonC. Screening for colorectal cancer: A comparison of 3 fecal occult blood tests. Arch Intern Med1997;157:970–6.
21.
KingJFairbrotherGThompsonCColorectal cancer screening: Optimal compliance with postal faecal blood test. Aust N Z J Surg1992;62:714–9.
22.
JosephA. Compliance with fecal occult blood testing: The role of restrictive diets. Am J Public Health1988;78:839–41.
23.
RobinsonMHEPyeGThomasWMHaemoccult screening for colorectal cancer: The effect of dietary restriction on compliance, Europ J Surg Oncol1994;20:545–8.
24.
ColeSRYoungGP.Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust2001;175:195–8.
25.
WellerDPOwenNHillerJEColorectal cancer and its prevention: Prevalence of beliefs, attitudes, intentions and behaviour. Aust J Pub Health1995;19:19–23.
26.
MyersREVernonSWTilleyBCIntention to screen for colorectal cancer among white male employees. Prev Med1998;27:279–87.
27.
LiTNakamaHWeiN. Reasons for non-compliance in colorectal cancer screening with fecal occult blood test. Eur J Med Res1998;3:397–400.
28.
FrewEWolstenholmeJWhynesD. Mass population screening for colorectal cancer: Factors influencing subjects' choice of screening test. J Health Serv Res Policy2001;6:85–91.
29.
AhlquistDASchwartzSIsaacsonJA stool collection device: The first step in occult blood testing. Ann Intern Med1988;108:609–12.
30.
NakamaHFattahAZhangBA comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Hepato-Gastroenterol2000:47:386–9.
31.
NakamaHKamijoNMiyataKSensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol1998;45:1579–82.
32.
SaitoHSomaYNakajimaMA case-control study evaluating occult blood screening with Hemoccult test and an immunochemical hemagglutination test. Oncol Reports2000;7:815–9.
33.
YoungGPMacraeFASt JohnDJB.Clinical methods of early detection: Basis, use and evaluation. In: YoungGPLevinBRozenP, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996: 241–70.
34.
RozenPKnaaniJSamuelZ. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test within an endoscopy study. Cancer2000;89:46–52.
35.
GardnerMJAltmanDG.Confidence intervals rather than P values: Estimation rather than hypothesis testing. BMJ1986;292:746–50.
36.
WhynesDKWalkerARHardcastleJD.Cost-effective screening strategies for colorectal cancer. J Pub Health Med1992;14:43–9.
37.
RasmussenMKronborgO. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol2001;37:95–8.
38.
YoungGP.Screening for colorectal cancer: Alternative faecal occult blood tests. Eur J Gastroenterol Hepatol1998;10:205–212.
39.
RozenPKnaaniJSamuelZ. Performance characteristics and comparison of two immunochemical and two guaiac faecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci1997;42:2064–71.
40.
RozenPKnaaniJSamuelZ. Eliminating the need for dietary restrictions when using a sensitive guaiac faecal occult blood test. Dig Dis Sci1999;44:756–60.
41.
NakamaHFattahASMAZhangBA comparative study of immunochemical faecal tests for detection of colorectal adenomatous polyps. Hepato-Gastroenterol2000:47:386–9.
42.
NakamaHKamijoNMiyataKSensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol1998;45:1579–82.
43.
AtkinWSMorsonBCCuzickJ. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med1992;326:658–62.
44.
MacraeFASt JohnDJB.Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology1982;82:891–8.
45.
VernonS. Participation in colorectal cancer screening: A review. J Natl Cancer Inst1997;89:1406–22.